Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment-Reference-Cited by-同舟云学术

Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment

Published:2015-06-09 Issue:10 Volume:20 Page:1179-1187
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Brendel M,Jaworska A,Herms J,Trambauer J,Rötzer C,Gildehaus F-J,Carlsen J,Cumming P,Bylund J,Luebbers T,Bartenstein P,Steiner H,Haass C,Baumann K,Rominger A

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/mp201574.pdf

Reference44 articles.

1. Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM . Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement 2008; 4: 316–323.

2. Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239–259.

3. Haass C, Selkoe DJ . Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101–112.

4. Sun X, Jin L, Ling P . Review of drugs for Alzheimer's disease. Drug Discov Ther 2012; 6: 285–290.

5. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ . Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003; 348: 1333–1341.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases;The EMBO Journal;2024-02-23

2. Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease;Frontiers in Molecular Neuroscience;2023-10-16

3. PET Imaging in Preclinical Anti-Aβ Drug Development;Pharmaceutical Research;2022-05-02

4. γ-Secretase in Alzheimer’s disease;Experimental & Molecular Medicine;2022-04-08

5. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition;Frontiers in Aging Neuroscience;2022-03-30